ABCL AbCellera Biologics Year-over-year net earnings per share growth for the last 12 months

AbCellera Bio - graphic logo of issuer ABCL

AbCellera Biologics (ABCL) revenues rely on royalties from legacy contracts that are currently entering a renewal phase. The quarterly EPS trend captures the speed of this recovery, with the metric reaching 33.30. Growth is driven by licensing fees from Big Pharma and government R&D support. A competitive advantage is provided by patented microfluidics for AI-powered antibody discovery.

AbCellera Biologics Inc. (ABCL) Year-over-year earnings per share growth for the last 12 months: for the period 07/04/2022 - 11/15/2026

ABCL (abcellera.com): analytical breakdowns and indicator data

- market value and analyst target forecast:
Fundamental valuation:AbCellera Bio - ABCL
Flagship merchandise of AbCellera Biologics

Quarterly EPS growth measures the dynamics of net income per share relative to the same period last year. This metric assesses cost management efficiency and the business's ability to scale profitability. By analyzing the current quarterly EPS rate, an investor determines the sustainability of the operating model. For AbCellera (ABCL), this is critical amid fierce competition with major CROs. The indicator confirms the company's ability to monetize scientific breakthroughs despite the expansion of internal AI laboratories by pharma behemoths.

Main competitors

argenx BVBA (ARGX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BioNTech SE|Year-over-year net earnings per share growth for the last 12 months ABVX|Quarterly EPS earnings growth admabiologics.com|Year-over-year earnings per share growth for the last twelve months Protagonist Therapeutics Inc (PTGX)|Immunovant - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth KNSA (kiniksa.com)|Grifols Group (GRFS) - Earnings per share growth in annualized terms for the last twelve months|Adaptive Biotechnologies Inc. - Quarterly EPS earnings growth|Celldex Therapeutics (CLDX) - Year-over-year net earnings per share growth for the last 12 months|AUPH (auriniapharma.com) - Year-over-year net earnings per share growth for the last 12 months|BCRX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Vera Pharma|Quarterly EPS earnings growth Dianthus Corp|Year-over-year earnings per share growth for the last twelve months Pharvaris N.V. (PHVS)|TRML (tourmalinebio.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth PGEN (Precigen Inc)|PHAR - Year-over-year net earnings per share growth for the last 12 months|NKTR - Year-over-year earnings per share growth for the last twelve months|UPB - Quarterly EPS earnings growth|ZBIO: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Immunome, Inc.|Year-over-year earnings per share growth for the last twelve months Gossamer Bio|Quarterly EPS earnings growth KalVista Pharmaceuticals Inc|Year-over-year net earnings per share growth for the last 12 months SEPN (Septerna Corp)|PVLA (Pieris Pharmaceuticals Inc) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth SVRA (savarapharma.com)|Year-over-year earnings per one share growth for the last 12 months RIGL|ANAB: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months ATXS (Astria Therapeutics, Inc.)|ENGN: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months RAPT Therapeutics, Inc. (RAPT)|Year-over-year earnings per share growth for the last twelve months aerovatetx.com|Quarterly EPS earnings growth aclaristx.com|Year-over-year earnings per share growth for the last twelve months Kyverna Therapeutics (KYTX)|Year-over-year net earnings per share change for the last twelve months Tiziana Life Sciences Ltd|Quarterly EPS earnings growth CABA (Cabaletta Bio Inc)|VTYX: Year-over-year earnings per share growth for the last 12 months|Theratechnologies, Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Avalo Therapeutics, Inc AVTX|ELDN (Eledon Pharmaceuticals) - Year-over-year net earnings per share growth for the last 12 months|Agenus Inc. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Climb Bio|Quarterly EPS earnings growth Zura Bio Ltd|Year-over-year net earnings per share growth for the last 12 months ATYR (aTyr Pharma Inc)|Year-over-year net earnings per share change for the last twelve months Adagene Inc|Year-over-year earnings per share growth for the last twelve months ImageneBio Inc IMA|Year-over-year earnings per share growth rate for the last twelve months STTK (shattucklabs.com)|EQ: Year-over-year net earnings per share growth for the last 12 months|CNTB: Year-over-year earnings per share growth for the last twelve months|IMUX: Quarterly EPS earnings growth|Atara Biotherapeutics (ATRA) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months IFRX|Quarterly EPS earnings growth X4 Pharmaceuticals Inc.|Year-over-year earnings per share growth for the last twelve months Adicet Bio Inc. (ACET)|Year-over-year net earnings per share growth for the last 12 months Celularity CELU|Quarterly EPS earnings growth INMB (INmune Bio Corporation)|Year-over-year net earnings per share change for the last twelve months Barinthus Biotherapeutics (BRNS)|KZR - Year-over-year earnings per share growth for the last twelve months|SABS - Quarterly EPS earnings growth|Akari Therapeutics, Plc (AKTX) - Year-over-year earnings per share growth for the last twelve months|Enlivex Therapeutics, Ltd. (ENLV) - Quarterly EPS earnings growth|QTTB (Q32 Bio Inc) - Quarterly EPS earnings growth|geovax.com (GOVX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months EDSA (Edesa Biotech)|Year-over-year net earnings per share change for the last twelve months iBio Inc|Quarterly EPS earnings growth CARM (Carisma Therapeutics Inc)|Year-over-year earnings per one share growth for the last 12 months XTLB|BOLT: Year-over-year net earnings per share growth for the last 12 months|HCW Biologics (HCWB) - Year-over-year net earnings per share growth for the last 12 months|Aptevo (APVO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months AIM ImmunoTech|Year-over-year net earnings per share growth for the last 12 months ADTX|GRI Bio Corporation (GRI) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months XRTX (XORTX Therapeutics Inc.)|Vyome Holdings Inc - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Revelation Biosciences Inc REVB|INDP - Year-over-year net earnings per share growth for the last 12 months|SCNI: Year-over-year net earnings per share growth for the last 12 months|CALI: Year-over-year earnings per share growth for the last twelve months|AFMD: Quarterly EPS earnings growth|Allakos Inc - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months HOOKIPA Pharma, Inc.|IGM Biosciences, Inc. (IGMS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months iteostherapeutics.com (ITOS)|OCEA - Earnings per share growth in annualized terms for the last twelve months|TC BioPharm (Holdings) PLC - Year-over-year net earnings per share growth for the last 12 months|THRD: Year-over-year earnings per share growth for the last 12 months